This year the INFORM 2018 Symposium will be held in Athens,                               Greece preceding the SSIEM. The venue for this two day event                                 will be the Divani Caravel Hotel, Leof. Vasileos Alexandrou 2,                                 Athens 161 21, Greece. 


                             INFORM is held annually to provide a collaborative framework                                 for ongoing communication and research in the diagnosis and                               treatment of disorders of fatty acid oxidation and the carnitine                               cycle.  Please view our agenda which you will see is packed                                     with information on recent advances to be shared among this international group of FAOD experts and clinicians. In May Seven Travel Grant recipient will be awarded to round out the schedule. 

All Abstracts selected for INFORM 2018 will be able to post them during the Poster Presentation on Monday September 3rd.  Seven investigators will be selected to present during the symposium.  All others not receiving a grant will have the opportunity ​to present during a scheduled 10 min time frame at their poster Monday afternoon. We look forward to a positive response.


On behalf of the symposium planning committee I want to thank you for your past participation at INFORM and look forward to seeing you in Athens.
  
Best regards,

Jerry 
INFORM Co-Chair and Scientific Organizer


    2018 INFORM Sponsors 

Personal Sponsorship
Ruben Bonilla Guerrero, MD, FACMG, FACB 

Registration is NOW Open ...Click the image above.

International Network for Fatty Acid Oxidation Research and Management 

Below are the recipients of the 2018 INFORM Travel Grants.  Congratulations!

Yudong Wang - Characterizing the Molecular Architecture of Mitochondrial Energy Metabolism 

Oleg Varlamov - Altered fiber type distribution, reduced lipid transport, and decreased carnitine concentrations in skeletal muscle of subjects with fatty acid oxidation disorders

Suzan J.G. Knottnerus - Reduction of acylcarnitines restores electrophysiological abnormalities in VLCAD deficient hiPSC-cardiomyocytes 

Ermal Aliu – Restoration of VLCAD in Knockout Mice and Deficient Human Fibroblasts using Novel mRNA Technology: A Model to Treat Fatty Acid β-Oxidation Disorders 

Paschalis-Thomas Doulias - Novel therapeutics for fatty acid oxidation disorders 

Suzan Knottnerus - Metabolomics profiling in dried blood spots differentiates clinical phenotypes in VLCADD 

Yuxun Zhang - Mitochondrial H2O2 Generation Via the Acyl-CoA Dehydrogenases

Honorable Mentions
Adrianus J. Bakermans - Cardiac magnetic resonance imaging and spectroscopy in patients with long-chain fatty acid β-oxidation deficiency 

Zeinab Wehbe - Sex specific metabolic phenotype in very-long chain acyl-CoA dehydrogenase deficient (VLCAD-/-) mice 

Zahra Nochi - A novel loss of function FLAD1 variant, causing riboflavin-responsive multiple acyl-CoA dehydrogenase deficiency (MADD)Type your paragraph here.

Children’s Hospital of Pittsburgh/UPMC - Medical Genetics - One Children's Hospital Drive
Faculty Pavilion 1st Floor - 4401 Penn Avenue - Pittsburgh, PA 15224
​Office:  412.692.5099  
 Keith McIntire -  Coordinator, INFORM - keith.mcintire@chp.edu

Jerry Vockley, MD, PhD

​​​​​​​INFORM 2018
​September 2nd & 3rd in Athens Greece preceding the SSIEM

Support provided by Ultragenyx Pharmaceutical Inc. ​&​ by an Unrestricted Educational Grant from Acer Therapeutics Inc